Drug Contamination Data On Semipermeable Vials Should Be Collected By FDA
Executive Summary
FDA needs to collect toxicology data on the potential contamination of drug products packaged in semipermeable containers, the agency's Drug Safety & Risk Management Advisory Committee recommended